RB1 and neoplasm: Focal MYCN amplification was present in four eyes (6.3%; Cases 3, 10, 31, and 48); the presence of MYCN amplification does not necessarily denote a MYCN-driven tumor which clearly Case 10 is not (germline RB1 mutation present).